To access this element change to forms mode OFF
Grant Award View - GA30001
Novel feedback inhibition of AMPK by mTORC1 controls cell proliferation...
GA ID:
GA30001
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$625,788.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Novel feedback inhibition of AMPK by mTORC1 controls cell proliferation under stress
Purpose:
Cancer is a disease of uncontrolled cell growth and division. The AMP-activated protein kinase (AMPK) is the cell’s main energy sensor. AMPK provides protection against cancer, in part through its inhibition of mitosis and cell division. AMPK and TOR signalling is altered in most tumours and better understanding of nutritional control of these signalling pathways offers great potential for better selective therapeutic strategies.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1161262
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Flinders University
Recipient ABN:
65 542 596 200
Grant Recipient Location
Suburb:
Bedford Park
Town/City:
Bedford Park
Postcode:
5042
State/Territory:
SA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC, SA
Postcode:
Multiple
Country:
AUSTRALIA